view counter

Boston Scientific Corp.

1 Boston Scientific Place
Natick
MA
01760-1537
United States
Product(s): 
Manufactures stents, pacemakers, pain management and endosurgery products
Employees: 
25000
Ownership: 
Public
Exchange: 
NYSE
symbol: 
BSX
2004 Revenue: 
$5,624,000,000
2005 Revenue: 
$6,283,000,000
2006 Revenue: 
$7,821,000,000
2007 Revenue: 
$8,357,000,000
2008 Revenue: 
$8,050,000,000
2009 Revenue: 
$8,188,000,000
Yahoo Quotes: 

Chairman: 
Pete M. Nicholas
President: 
J. Raymond Elliot
Management: 
J. Raymond Elliot, Director/President/CEO
Donald S. Baim, EVP/CMO/CSO
Brian R. Burns, SVP-Quality
Jeffrey D. Capello, EVP, CFO
Fredericus A. Colen, EVP/CTO
Joseph M. Fitzgerald, SVP, President Endovascular
Jim Gilbert, EVP-Strategy & Business Development
William H. (Hank) Kucheman, SVP/Pres. Cardiology, Rhythm and Vascular Group
Samuel R. Leno, EVP-Finance & Information Systems/COO
William F. McConnell Jr., SVP-Sales, Marketing & Business Strategy, cardiac rhythm management
David McFaul, SVP-International
Stephen F. Moreci, SVP/Global Sales
Michael Onuscheck, SVP/President-Neuromodulation
Timothy A. Pratt, EVP/Secretary, General Counsel
Kenneth J. Pucel, EVP-Operations
Lucia Luce Quinn, EVP-HR
Paul Donovan, SVP- Corporate Communications
Boston Scientific Corp.
browse jobs and career opportunities in the medical devices industry
view counter
META's Needs Assessment System measures the gap between ideal and current sales performance
view counter
Free Literature and Charts from Emergo Group
view counter
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp